FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

31 letters match. Newest first.

  1. Olympus Medical Systems Corporation

    FDA warns Olympus over quality-system failures across six medical device plants, including unvalidated designs and released nonconforming devices.

    High risk
  2. Unilam Co., LTD

    Unilam Co., LTD's UV sunlamps violate quality-system and radiation-safety testing rules, FDA says.

    High risk
  3. Specialty Health Products CO, LLC

    Specialty Health Products was cited for quality-system, unapproved marketing, and listing violations for its Hydro-San and Aqua Cleanse colonic irrigation devices.

    High risk
  4. ZOLL Medical Corporation

    FDA warned ZOLL Medical after an inspection found quality-system, design-validation, supplier, and reporting failures for defibrillators, ventilators, and electrodes.

    High risk
  5. Abbott Diabetes Care, Inc.

    FDA warns Abbott Diabetes Care that FreeStyle Libre 3 glucose monitors lacked design transfer and finished-device accuracy release testing.

    High risk
  6. Envoy Medical Inc.

    Envoy Medical in Saint Paul, MN was cited for quality system failures in making its Esteem II Implantable Hearing System, including slow complaint investigations and missed cleanroom contamination risks.

    High risk
  7. Contec Medical Systems Co., Ltd.

    FDA warns Chinese device maker Contec Medical Systems over quality system failures; its patient monitors and ultrasound devices face US border detention.

    High risk
  8. Uscom Kft

    Uscom Kft marketed SpiroSonic AIR spirometer in the U.S. without FDA clearance and had multiple quality system failures at its Budapest plant.

    High risk
  9. Visgeneer, Inc

    FDA warns Taiwan maker Visgeneer over design validation and complaint handling failures for blood glucose and uric acid meters.

    High risk
  10. Aju Pharm Co., Ltd.

    FDA warns Aju Pharm over unvalidated Fixone suture anchors and multiple quality-system failures.

    High risk
  11. Sedecal S.A.

    Sedecal S.A. warned for quality-system and reporting failures on mobile x-ray systems.

    High risk
  12. Noah Medical Corporation

    FDA warns Noah Medical of San Jose, CA over quality system failures and missed injury reports for its Galaxy bronchoscopes.

    High risk
  13. EpiCare Acquisitions, LLC

    FDA warns EpiCare Acquisitions over unvalidated EpiCare-Zenith lasers and flawed complaint, corrective-action, record, training, and reporting procedures.

    High risk
  14. Next Science LLC

    FDA warns Next Science that wound gels and irrigation solutions are adulterated and misbranded for uncleared claims and quality failures.

    High risk
  15. Hologic, Inc.

    FDA warns Hologic over design-control and reporting failures for implantable BioZorb markers, including missed medical device reports and a correction report.

    High risk
  16. Becton, Dickinson, and Company/CareFusion 303, Inc.

    FDA warned Becton Dickinson/CareFusion over Pyxis medication dispensing systems with unresolved software defects, missed MDR reports and unreported recalls.

    High risk
  17. Rolence Ent. Inc.

    FDA warns Rolence Ent. Inc. over quality system and MDR failures for its XR-01 Portable X-ray System.

    High risk
  18. Micro-X Ltd.

    FDA warns Australia's Micro-X over design, CAPA and complaint failures on Rover mobile x-ray systems, plus unreported field corrections.

    High risk
  19. Criticare Technologies, Inc.

    FDA warns Criticare Technologies over patient monitors after finding unresolved CAPAs, weak design controls and supplier checks at its Warwick, Rhode Island plant.

    High risk
  20. Exactech, Inc.

    Exactech shoulder and hip implants had quality-system and medical-device reporting failures, including a late GXL liner wear report.

    High risk
  21. Fresenius Kabi AG

    FDA warned Fresenius Kabi about quality and reporting failures for its Ivenix Infusion System.

    High risk
  22. Barkey GmbH & Co. KG

    FDA warns Barkey over unapproved plasmatherm V blood thawing device and missing design risk analysis.

    High risk
  23. Sonesta Medical AB

    FDA warned Sonesta Medical AB that its radiographic and cystometric tables violated device quality system rules.

    Medium
  24. Fresenius Medical Care AG & Co. KGaA

    FDA warns Fresenius over delayed fixes and reporting for PCB leaching from silicone tubing in hemodialysis machines.

    High risk
  25. Acrostak Schweiz AG

    FDA warns Acrostak Schweiz that its M-Cath Flexy Microcatheter was marketed without required 510(k) clearance (FDA marketing permission) and has quality-system violations.

    High risk
  26. Neurotris, Inc. dba A1 Engineering

    FDA warns Neurotris over unapproved, misbranded facial/body stimulator devices and quality system violations.

    High risk
  27. Tesla BioHealing, Inc.

    FDA warns Tesla BioHealing over unapproved MedBed and BioHealer devices marketed for serious diseases.

    High risk
  28. Turkuaz Sağlik Hizmetleri Medikal Temizlik Kimyasa

    FDA warns Turkish ultrasound gel maker Turkuaz over broad quality-system violations found in 2022 inspection.

    High risk
  29. Aizu Olympus Co., Ltd.

    Aizu Olympus failed to validate endoscope designs and manufacturing processes and lacked MDR procedures, FDA says.

    High risk
  30. Smiths Medical ASD Inc.

    FDA cites Smiths Medical for unreported Medfusion pump malfunctions and quality-system failures at its Minneapolis facility.

    High risk
  31. DeChoker LLC

    FDA warned DeChoker LLC that its choking-victim suction device was made with unvalidated processes and lacked design validation and adequate CAPA records.

    High risk